The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBank Of Ireland Regulatory News (BIRG)

Share Price Information for Bank Of Ireland (BIRG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.56
Ask: 9.95
Change: -0.095 (-0.96%)
Spread: 0.39 (4.079%)
Open: 9.60
High: 9.915
Low: 9.60
Prev. Close: 9.845
BIRG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tracker Mortgage Examination Review update

9 Nov 2017 14:30

RNS Number : 0814W
Bank of Ireland Group PLC
09 November 2017
 

Bank of Ireland Group plc (the ''Group'')

Group sets out path for resolution of Tracker Mortgage Examination Review

 

9 November 2017

 

Further to the Group's announcement on 26 October 2017, the Group is today providing an update in relation to the Tracker Mortgage Examination Review being undertaken by the Central Bank of Ireland.

 

Of the c.4,3001 impacted customers already identified, c.600 of these relate to accounts where a right to, or the option of, a tracker rate of interest was not appropriately provided to the customer in accordance with their loan documentation. For these customers, the Group has commenced the communication and compensation process including:

 

· Customers from this group were returned to their correct tracker rate between December 2016 and April 2017.

· Customers will shortly be written to with a full offer of compensation and advising customers of the options open to them.

· Our process is designed to compensate all of these customers, subject to their agreement, by the end of this year.

 

In addition, the Group has engaged in recent weeks with the Central Bank of Ireland as the Group nears completion of its review to determine whether further customers should be included in the scope of the compensation scheme.

 

It is the Group's objective to fully resolve the Tracker Mortgage Examination Review. On this basis, the Group has therefore decided to include an additional c.6,000 accounts within the scope of the compensation scheme. As a consequence, the Group will be making an additional provision in its financial accounts in Q4 2017 of between €150 million and €175 million primarily in respect of redress and compensation associated with these additional c.6,000 accounts. The Group will ensure that all impacted customers who continue to have an open mortgage account will be returned to their correct tracker rate as soon as possible. The Group aims to compensate all impacted customers, subject to their agreement, as quickly as possible starting before the end of 2017.

 

Francesca McDonagh, Group Chief Executive Officer said:

 

"I unreservedly apologise to all impacted customers for the financial loss and anxiety this has caused them and their families.

 

The bank is also confirming today that c.6,000 additional customers will be part of the compensation scheme. This now gives us a clear picture of the number of impacted customers. The compensation process is commencing, and our priority is to ensure that all impacted customers are compensated as quickly as possible."

 


1As set out in the Group's Interim Management Statement on 26 October 2017, the Group had separately identified a small rate differential (average 0.15%) on c.3,700 tracker mortgages which was not the appropriate rate specified in the loan documentation. These customers have already been returned to their correct tracker rate between March 2016 and August 2017 and the Group has commenced the communication and compensation process. All impacted customers will shortly be written to with a full offer of compensation and advising customers of the options open to them. Our process is designed to compensate all of these customers, subject to their agreement, by the end of this year.

 

The expected financial impact of the above is as follows:

 

· The re-instatement of mortgages to a tracker rate (current outstanding value of c.€375 million) is expected to reduce the Group's net interest margin from 2018 onwards by c.1bp.

· The Group will be making an additional provision in its financial accounts in Q4 2017 of between €150 million and €175 million in respect of these additional c.6,000 accounts.

· On a pro-forma basis at September 2017, the provision in Q4 2017 will reduce the Group's transitional CET1 ratio to c.14.4% from 14.7% and the Group's fully loaded CET1 ratio to c.12.5% from 12.8%.

 

 

Ends

 

For further information please contact:

 

Bank of Ireland

 

Andrew Keating Group Chief Financial Officer +353 (0)766 23 5141

Alan Hartley Director of Group Investor Relations +353 (0)766 23 4850

Pat Farrell Head of Group Communications +353 (0)766 23 4770

 

 

 

Forward Looking Statement

 

This announcement contains certain forward-looking statements with respect to certain of the Group's plans and its current goals and expectations relating to its future financial condition and performance, the markets in which it operates, and its future capital requirements. These forward-looking statements often can be identified by the fact that they do not relate only to historical or current facts. Generally, but not always, words such as 'may,' 'could,' 'should,' 'will,' 'expect,' 'intend,' 'estimate,' 'anticipate,' 'assume,' 'believe,' 'plan,' 'seek,' 'continue,' 'target,' 'goal', 'would,' or their negative variations or similar expressions identify forward-looking statements, but their absence does not mean that a statement is not forward looking. Examples of forward-looking statements include among others, statements regarding the Group's near term and longer term future capital requirements and ratios, loan to deposit ratios, expected impairment charges, the level of the Group's assets, the Group's financial position, future income, business strategy, projected costs, margins, estimates of capital expenditures, discussions with Irish, United Kingdom, European and other regulators and plans and objectives for future operations.

 

Nothing in this announcement should be considered to be a forecast of future profitability, dividends or financial position and none of the information in this document is or is intended to be a profit forecast, profit estimate or dividend forecast. Any forward-looking statement speaks only as at the date it is made. The Group does not undertake to release publicly any revision to these forward-looking statements to reflect events, circumstances or unanticipated events occurring after the date hereof.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUKASRBBAARAA
Date   Source Headline
10th May 202410:00 amRNSDirector/PDMR Shareholding
10th May 20248:41 amRNSFinal Dividend: Timetable
10th May 20247:00 amRNSTransaction in Own Shares
9th May 20247:00 amRNSTransaction in Own Shares
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20248:26 amRNSPre Stabilisation Notice - Bank of Ireland Tier 2
1st May 202410:16 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSInterim Management Statement – Q1 2024
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20243:15 pmRNSTotal Voting Rights
19th Apr 20243:10 pmRNSNotice of AGM
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 202410:00 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20249:35 amRNSNotification of Major Holdings
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20241:35 pmRNSNotification of Major Holdings
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 202410:14 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.